TREA

88955542 - GLOBAL PATHOGEN SHIELD

Follow

Information

  • Trademark
  • 88955542
  • Serial Number
    88955542
  • Filing Date
    June 09, 2020
    4 years ago
  • Transaction Date
    September 15, 2024
    7 months ago
  • Status Date
    August 05, 2024
    8 months ago
  • Published for Opposition Date
    May 04, 2021
    3 years ago
  • Location Date
    January 12, 2024
    a year ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    BEGGS, MONICA
  • Attorney Docket Number
    F06702001000
    Attorney Name
    Christina M. Licursi
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
4
Mark Identification
GLOBAL PATHOGEN SHIELD
Case File Statements
  • GS0411: educational services, namely, conducting classes, seminars, and workshops in the field of public health and research and development related to infectious disease and distribution of educational materials in connection therewith; education services, namely, providing on-line instruction in the field of public health and the prevention, infection, and detection of infectious disease via an online website; educational services, namely, conducting classes, seminars, conferences and workshops in the fields of pharmaceutical and biotechnological product development, medical device development, public health, chronic diseases, infectious diseases, and economic development; educational services, namely, developing curriculum for others in the field of medical research; developing trainings for others regarding safety and health measures and preparing screening and monitoring protocols to address exposure to infectious disease
  • GS0091: Diagnostic products and devices for use in detecting infectious disease, namely, diagnostic apparatus for the detection of pathogens for laboratory and research use; downloadable software for tracking and reporting incidence of infectious disease; downloadable software for use in the analysis of health and environmental data; downloadable software for use in the analysis of healthcare data from patients to determine rates, trends, patterns, and causative factors contributing to incidence of infectious disease; research and development tools relating to infectious diseases for research facilities and vaccine manufacturing facilities, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; research tools, namely, downloadable software for use in conducting infectious disease and public health research; research tools, namely, downloadable electronic databases in the field of infectious disease and public health research; scientific collaboration tools for researching and testing treatments for infectious disease, namely, downloadable computer software for collaborating on shared documents and data; surveillance tools for infectious disease being tools for monitoring infectious disease, namely, downloadable software featuring disease spread analytics and graphics, downloadable databases featuring disease spread analytics and graphics; electronic tools in the nature of downloadable software used to predict, identify and characterize pathogen threats to individuals and populations
  • GS0051: diagnostic products for use in detecting and treating infectious disease, namely, medical diagnostic reagents and diagnostic preparations for medical purposes
  • GS0351: Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare, via a consortium, collective, and initiative of companies that collaborate to globally prevent, detect, and treat infectious disease; providing a website featuring business information about recruiting participants for clinical research and maintaining a consortium relating to the prevention, infection, and detection of infectious disease; maintaining a registry of participants on the Internet for clinical research relating to the prevention, infection, and detection of infectious disease; healthcare management and consulting services in connection with infectious disease, namely, business and management consulting for healthcare providers and related businesses and consulting in the field of healthcare operations management; developing worksite specific epidemic risk scoring profiles, namely, business risk management and healthcare business risk management consultation; consulting on healthcare public relations communication strategies; new investment and business models to drive research and development and innovation in the infectious disease space, namely, business advisory services and business consultancy with regard to reducing the spread of infectious diseases
  • GS0451: subscription-based security system to prevent, detect, treat infectious disease being emergency response alarm monitoring services, namely, monitoring of alert devices by a remote monitoring center for the dispatch of emergency public health services and notification to third parties
  • GS0441: Providing a website featuring medical and health information about infectious disease; providing an on-line computer database featuring medical and health information in the field of infectious disease; subscription-based security system to prevent, detect, treat infectious disease, namely, an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; consulting services in the field of healthcare in connection with infectious disease; developing worksite specific epidemic risk scoring profiles in the nature of healthcare consultation in the field of infectious diseases; providing a website featuring healthcare information about recruiting participants for clinical research and maintaining a consortium relating to the prevention, infection, and detection of infectious disease; new investment and business models to drive research and development and innovation in the infectious disease space, namely, healthcare advisory services and healthcare consultancy with regard to reducing the spread of infectious diseases
  • DS0000: "GLOBAL PATHOGEN"
  • GS0421: Providing an on-line computer database featuring medical research information in the field of infectious disease; research and development in the field of infectious diseases for research facilities and vaccine manufacturing facilities; research and development in the field of pharmaceutical and therapeutic development and medical device development; clinical research services in the field of medical care, namely, conducting clinical trials for others and scientific research; medical research in the nature of conducting laboratory, clinical and public health research, all for the medical and biomedical fields in the fields of infectious diseases and vaccines sciences, population science, and health systems research; providing temporary use of online, non-downloadable software for tracking and reporting incidence of infectious disease; providing temporary use of online, non-downloadable software for use in the analysis of health and environmental data; providing temporary use of online, non-downloadable software for use in the analysis of healthcare data from patients to determine rates, trends, patterns, and causative factors contributing to incidence of infectious disease; scientific and medical research in the fields of health, healthcare, infection prevention and control, and infectious diseases; product research, design and development in the fields health, healthcare, infection prevention and control, and infectious diseases; product research, design and development of medical devices, products and technologies in the fields of health, healthcare, infection prevention and control, and infectious diseases; design and development of healthcare products to improve healthcare services and build health systems; quality management services, namely, quality evaluation and analysis, quality assurance, quality control and product quality improvement, all in the fields of health, healthcare, infection prevention and control, and infectious diseases; developing quality control and voluntary standards and guidelines being protocols to address exposure to infectious disease, all for the delivery and rendition of healthcare services; developing worksite specific epidemic risk scoring profiles in the nature of scientific research consultation in the field of infectious diseases; developing intervention protocols, namely, development of voluntary standards for addressing exposure of infectious disease; research tools, namely, providing temporary use of online, non-downloadable software for use in conducting infectious disease and public health research; research tools, namely, providing an online searchable databases in the field of infectious disease and public health medical and scientific research; scientific collaboration tools and services for researching and testing treatments for infectious disease, namely, providing temporary use of a non-downloadable web application for collaborating on shared documents and data; surveillance tools and services for infectious disease being tools for monitoring infectious disease, namely, providing temporary use of online non-downloadable software for use in environmental monitoring and sampling air or surfaces
Case File Event Statements
  • 9/15/2020 - 4 years ago
    3 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 7/2/2020 - 4 years ago
    1 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/11/2020 - 4 years ago
    2 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/15/2020 - 4 years ago
    4 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/15/2020 - 4 years ago
    5 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/4/2020 - 4 years ago
    6 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/4/2020 - 4 years ago
    7 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/5/2020 - 4 years ago
    8 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 12/28/2020 - 4 years ago
    9 - FINAL REFUSAL WRITTEN Type: CNFR
  • 12/28/2020 - 4 years ago
    10 - FINAL REFUSAL E-MAILED Type: GNFR
  • 12/28/2020 - 4 years ago
    11 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 3/26/2021 - 4 years ago
    12 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 3/26/2021 - 4 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/27/2021 - 4 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/1/2021 - 4 years ago
    15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/1/2021 - 4 years ago
    16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 4/1/2021 - 4 years ago
    17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 4/1/2021 - 4 years ago
    18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 4/1/2021 - 4 years ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/14/2021 - 4 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/23/2021 - 4 years ago
    21 - TEAS PETITION TO DIRECTOR RECEIVED Type: TPDR
  • 5/4/2021 - 3 years ago
    22 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/4/2021 - 3 years ago
    23 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/20/2021 - 3 years ago
    24 - ASSIGNED TO PETITION STAFF Type: APET
  • 6/8/2021 - 3 years ago
    25 - PETITION TO DIRECTOR DENIED Type: PCDE
  • 6/29/2021 - 3 years ago
    26 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/22/2021 - 3 years ago
    27 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/22/2021 - 3 years ago
    28 - SOU EXTENSION 1 FILED Type: EXT1
  • 12/22/2021 - 3 years ago
    29 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 12/24/2021 - 3 years ago
    30 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/2/2022 - 2 years ago
    31 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/27/2022 - 2 years ago
    32 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/27/2022 - 2 years ago
    33 - SOU EXTENSION 2 FILED Type: EXT2
  • 6/27/2022 - 2 years ago
    34 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 6/29/2022 - 2 years ago
    35 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/15/2022 - 2 years ago
    36 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/27/2022 - 2 years ago
    37 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/27/2022 - 2 years ago
    38 - SOU EXTENSION 3 FILED Type: EXT3
  • 12/27/2022 - 2 years ago
    39 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 12/29/2022 - 2 years ago
    40 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 6/27/2023 - a year ago
    41 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 6/27/2023 - a year ago
    42 - SOU EXTENSION 4 FILED Type: EXT4
  • 6/27/2023 - a year ago
    43 - SOU EXTENSION 4 GRANTED Type: EX4G
  • 6/29/2023 - a year ago
    44 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 1/12/2024 - a year ago
    46 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 12/20/2023 - a year ago
    45 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/20/2023 - a year ago
    47 - SOU EXTENSION 5 FILED Type: EXT5
  • 1/12/2024 - a year ago
    48 - SOU EXTENSION 5 GRANTED Type: EX5G
  • 1/13/2024 - a year ago
    49 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 8/5/2024 - 8 months ago
    50 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 8/5/2024 - 8 months ago
    51 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6